Lyra Therapeutics' Nasal Matrix In Focus: Sniffing Out Opportunity Seeking Alpha, 09 Oct 2023 Summary Lyra Therapeutics' LYR-220 shows promise in addressing chronic rhinosinusitis, targeting a patient demographic that…